AstraZeneca | AZN - Ebit



AstraZeneca reported $3.51B in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Alcon AG USD 250M 261M Jun/2025
Almirall EUR 43.02M 3.42M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
argenx SE USD 288.02M 149.08M Jun/2025
AstraZeneca USD 3.51B 1.3B Jun/2025
Autolus Therapeutics Ltd -82608000 17.37M Jun/2025
Bayer EUR -36000000 2.95B Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Fresenius EUR 560M 94M Jun/2025
Fresenius Medical Care EUR 431M 15M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 432M 900.27M Jun/2025
Gilead Sciences USD 2.7B 189M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
GRIFOLS EUR 331.94M 57.97M Jun/2025
Haleon 568M 71M Dec/2024
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 727M 193M Dec/2024
Merck EUR 1.03B 26M Jun/2025
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Orion EUR 104.6M 26.7M Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Philips EUR 488M 134M Jun/2025
Recordati EUR 143.93M 51.87M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 608.6M Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Sanofi EUR 1.51B 1.39B Jun/2025
UCB EUR 502M 168M Dec/2024